Córdoba, R.; López-Corral, L.; Presa, M.; Martín-Escudero, V.; Vadgama, S.; Casado, M.Á.; Pardo, C.
The Health Impacts of Better Access to Axicabtagene Ciloleucel: The Case of Spain. Cancers 2024, 16, 2712.
https://doi.org/10.3390/cancers16152712
AMA Style
Córdoba R, López-Corral L, Presa M, Martín-Escudero V, Vadgama S, Casado MÁ, Pardo C.
The Health Impacts of Better Access to Axicabtagene Ciloleucel: The Case of Spain. Cancers. 2024; 16(15):2712.
https://doi.org/10.3390/cancers16152712
Chicago/Turabian Style
Córdoba, Raúl, Lucía López-Corral, María Presa, Victoria Martín-Escudero, Sachin Vadgama, Miguel Ángel Casado, and Carlos Pardo.
2024. "The Health Impacts of Better Access to Axicabtagene Ciloleucel: The Case of Spain" Cancers 16, no. 15: 2712.
https://doi.org/10.3390/cancers16152712
APA Style
Córdoba, R., López-Corral, L., Presa, M., Martín-Escudero, V., Vadgama, S., Casado, M. Á., & Pardo, C.
(2024). The Health Impacts of Better Access to Axicabtagene Ciloleucel: The Case of Spain. Cancers, 16(15), 2712.
https://doi.org/10.3390/cancers16152712
